help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 6, No. 11 1815-1824
doi:10.1210/me.6.11.1815
Copyright © 1992 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, Y. F.
Right arrow Articles by Albert, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Y. F.
Right arrow Articles by Albert, P. R.

Molecular Endocrinology, Vol 6, 1815-1824, Copyright © 1992 by Endocrine Society


ARTICLES

Cholera toxin-sensitive 3',5'-cyclic adenosine monophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A

YF Liu, O Civelli, QY Zhou and PR Albert
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.

The signal transduction pathways of the dopamine-D1 receptor were investigated in two cell types stably transfected with the human D1 receptor cDNA, rat pituitary GH4C1 cells (GH4-hD1), and mouse Ltk- fibroblast cells (L-hD1). In both GH4-hD1 and L-hD1 cell lines, stimulation of the dopamine-D1 receptor induced a marked increase in cAMP accumulation. In addition, dopamine potentiated activation of L- type voltage-dependent calcium channels in a cAMP-dependent manner in GH4-hD1 cells. However, in L-hD1 cells, dopamine increased cytosolic free calcium concentrations ([Ca++]i) by mobilization of intracellular calcium rather than by calcium influx. This effect was correlated with a dopamine-induced enhancement of phospholipase C activity in L-hD1 cells. Pretreatment (24 h) with cholera toxin (CTX) was used to maximally activate the GTP-binding protein (G protein) Gs, causing a maximal elevation of cAMP levels and uncoupling the D1 receptor from Gs. The described actions of dopamine in both cell lines were abolished by pretreatment with CTX, indicating that CTX substrates (e.g. Gs) may mediate these actions. The blockade by CTX was not due to CTX-induced elevation of cAMP, since pretreatment with forskolin or 8-bromo-cAMP to activate cAMP-dependent protein kinase did not inhibit dopamine actions nor alter basal [Ca++]i. Pretreatment (1-3 h) of L-hD1 cells with forskolin (10 microM) or 8-bromo-cAMP (5 mM) altered neither the basal activity of phospholipase C nor basal [Ca++]i in L-hD1 cells but greatly enhanced the dopamine-induced increase of phosphatidyl inositol turnover and [Ca++]i. From these results we conclude that: 1) the dopamine-D1 receptor induces multiple and cell-specific signals, including elevation of cAMP levels in both GH and L cells, cAMP- dependent activation and potentiation of opening of L-type voltage- dependent calcium channel in GH cells, and a novel phosphatidyl inositol-linked mobilization of cellular calcium in L cells; 2) coupling of the D1 receptor to these responses involves CTX-sensitive proteins, possibly Gs; and 3) acute preactivation of cAMP-dependent protein kinase can markedly enhance, rather than attenuate, certain pathways of dopamine-D1 transmembrane signaling.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. V. Neto, E. d. O. Machado, R. M. Luque, G. F. Taboada, J. B. Marcondes, L. M. C. Chimelli, L. P. Quintella, P. Niemeyer Jr., D. P. de Carvalho, R. D. Kineman, et al.
Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L.-Q. Ma, C. Liu, F. Wang, N. Xie, J. Gu, H. Fu, J.-H. Wang, F. Cai, J. Liu, and J.-G. Chen
Activation of Phosphatidylinositol-Linked Novel D1 Dopamine Receptors Inhibits High-Voltage-Activated Ca2+ Currents in Primary Cultured Striatal Neurons
J Neurophysiol, May 1, 2009; 101(5): 2230 - 2238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. P. Lee, C. H. So, A. J. Rashid, G. Varghese, R. Cheng, A. J. Lanca, B. F. O'Dowd, and S. R. George
Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal
J. Biol. Chem., August 20, 2004; 279(34): 35671 - 35678.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Gonzalez-Islas and J. J. Hablitz
Dopamine Enhances EPSCs in Layer II-III Pyramidal Neurons in Rat Prefrontal Cortex
J. Neurosci., February 1, 2003; 23(3): 867 - 875.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
A. Kulla and D. Manahan-Vaughan
Depotentiation in the Dentate Gyrus of Freely Moving Rats is Modulated by D1/D5 Dopamine Receptors
Cereb Cortex, June 1, 2000; 10(6): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. R. Albert, N. Sajedi, S. Lemonde, and M. H. Ghahremani
Constitutive Gi2-dependent Activation of Adenylyl Cyclase Type II by the 5-HT1A Receptor. INHIBITION BY ANXIOLYTIC PARTIAL AGONISTS
J. Biol. Chem., December 10, 1999; 274(50): 35469 - 35474.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ferre, M. Torvinen, K. Antoniou, E. Irenius, O. Civelli, E. Arenas, B. B. Fredholm, and K. Fuxe
Adenosine A1 Receptor-mediated Modulation of Dopamine D1 Receptors in Stably Cotransfected Fibroblast Cells
J. Biol. Chem., February 20, 1998; 273(8): 4718 - 4724.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON
Dopamine Receptors: From Structure to Function
Physiol Rev, January 1, 1998; 78(1): 189 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Obrietan and A. N. van den Pol
GABA Activity Mediating Cytosolic Ca2+ Rises in Developing Neurons Is Modulated by cAMP-Dependent Signal Transduction
J. Neurosci., June 15, 1997; 17(12): 4785 - 4799.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Drolet, L. Bilodeau, A. Chorvatova, L. Laflamme, N. Gallo-Payet, and M. D. Payet
Inhibition of the T-Type Ca2+ Current by the Dopamine D1 Receptor in Rat Adrenal Glomerulosa Cells: Requirement of the Combined Action of the G{beta}{gamma} Protein Subunit and Cyclic Adenosine 3',5'-Monophosphate
Mol. Endocrinol., April 1, 1997; 11(4): 503 - 514.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. M. Aherne, C. J. Vaughan, R. M. Carey, and D. P. O'Connell
Localization of Dopamine D1A Receptor Protein and Messenger Ribonucleic Acid in Rat Adrenal Cortex
Endocrinology, March 1, 1997; 138(3): 1282 - 1288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-Y. Yu, GilbertM. Eisner, I. Yamaguchi, M.M. Mouradian, RobinA. Felder, and PedroA. Jose
Dopamine D1A Receptor Regulation of Phospholipase C Isoform
J. Biol. Chem., August 9, 1996; 271(32): 19503 - 19508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Shimekake, K. Nagata, S. Ohta, Y. Kambayashi, H. Teraoka, K. Kitamura, T. Eto, K. Kangawa, and H. Matsuo
Adrenomedullin Stimulates Two Signal Transduction Pathways, cAMP Accumulation and Ca[IMAGE] Mobilization, in Bovine Aortic Endothelial Cells
J. Biol. Chem., March 3, 1995; 270(9): 4412 - 4417.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. L. Demchyshyn, K. S. Sugamori, F. J. S. Lee, S. A. Hamadanizadeh, and H. B. Niznik
The Dopamine D1D Receptor
J. Biol. Chem., February 24, 1995; 270(8): 4005 - 4012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Gomes and P. Soares-da-Silva
Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na+-K+-ATPase activity
Am J Physiol Renal Physiol, June 1, 2002; 282(6): F1084 - F1096.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society